CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-05 | BATE KENNETH Director | Sale | −1,008 | $485.54 | $489K | 7,888 |
| 2025-11-05 | BATE KENNETH Director | Sale | −827 | $486.73 | $403K | 7,061 |
| 2025-11-05 | BATE KENNETH Director | Sale | −2,775 | $487.49 | $1.4M | 4,286 |
| 2025-11-05 | BATE KENNETH Director | Sale | −696 | $489.09 | $340K | 3,590 |
| 2025-11-05 | BATE KENNETH Director | Sale | −933 | $489.95 | $457K | 2,657 |
| 2025-11-05 | BATE KENNETH Director | Sale | −30 | $490.98 | $15K | 2,627 |
| 2025-11-05 | BATE KENNETH Director | Option exercise · Stock Option (Right to Buy) | −5,470 | 0 | ||
| 2025-11-05 | BATE KENNETH Director | Option exercise · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2025-11-05 | BATE KENNETH Director | Option exercise · Stock Option (Right to Buy) | −1,105 | 0 | ||
| 2025-09-09 | Sibold William John President and CEO | Sale | −7,279 | $445.63 | $3.2M | 102,474 |
| 2025-08-21 | Sibold William John President and CEO | Sale 10b5-1 | −6,485 | $400.03 | $2.6M | 110,884 |
| 2025-08-21 | Sibold William John President and CEO | Sale 10b5-1 | −1,131 | $401.00 | $454K | 109,753 |
| 2025-08-20 | BAKER BROS. ADVISORS LP Director | Purchase | +480 | $380.44 | $183K | 198,240 |
| 2025-08-20 | BAKER BROS. ADVISORS LP Director | Purchase | +5,209 | $380.44 | $2.0M | 1,898,329 |
| 2025-08-20 | BAKER BROS. ADVISORS LP Director | Purchase | +176 | $380.78 | $67K | 198,416 |
| 2025-08-20 | BAKER BROS. ADVISORS LP Director | Purchase | +1,919 | $380.78 | $731K | 1,900,248 |
| 2025-08-20 | BAKER BROS. ADVISORS LP Director | Purchase | +873 | $381.12 | $333K | 199,289 |
| 2025-08-20 | BAKER BROS. ADVISORS LP Director | Purchase | +9,477 | $381.12 | $3.6M | 1,909,725 |
| 2025-08-20 | BAKER BROS. ADVISORS LP Director | Purchase | +105 | $382.29 | $40K | 199,394 |
| 2025-08-20 | BAKER BROS. ADVISORS LP Director | Purchase | +1,136 | $382.29 | $434K | 1,910,861 |
Page 14 of 82 · 1,629 trades